drugset / Trial / NCT00829998
Zaleplon 10mg Capsules Under Fasting Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to compare the relative bioavailability of Zaleplon 10 mg Capsules manufactured by TEVA Pharmaceuticals USA and Sonata® 10 mg Capsules manufactured by Wyeth Laboratories in healthy, non-smoking adults under fasting conditions.
Timeline
- Start
- 2004-02
- Primary completion
- 2004-02
- Completion
- 2004-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zaleplon | Small molecule | 10 mg | — |
Indications
No indication recorded.